Literature DB >> 20889885

Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections.

Sasisekhar Bennuru1, Grace Maldarelli, V Kumaraswami, Amy D Klion, Thomas B Nutman.   

Abstract

Lymphatic dilatation, dysfunction, and lymphangiogenesis are hallmarks of patent lymphatic filariasis, observed even in those with subclinical microfilaremia, through processes associated, in part, by vascular endothelial growth factors (VEGFs). A panel of pro-angiogenic factors was measured in the plasma of subjects from filaria-endemic regions using multiplexed immunological assays. Compared with endemic normal control subjects, those with both subclinical microfilaremia, and those with longstanding lymphedema had significantly elevated levels of VEGF-A, VEGF-C, VEGF-D, and angiopoietins (Ang-1/Ang-2), with only levels of basic fibroblast growth factor (bFGF) and placental growth factor (PlGF) being elevated only if lymphedema was evident. Furthermore, levels of these factors 1-year post-treatment with doxycycline were similar to pretreatment levels suggesting a minimal role, if any, for Wolbachia. Our data support the concept that filarial infection per se is associated with elevated levels of most of the known pro-angiogenic factors, with only a few being associated with the serious pathologic consequences associated with Wuchereria bancrofti infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889885      PMCID: PMC2946762          DOI: 10.4269/ajtmh.2010.10-0039

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  50 in total

1.  Basic fibroblast growth factor and fibrosis in Hodgkin's disease.

Authors:  K Ohshima; M Sugihara; J Suzumiya; S Haraoka; M Kanda; K Shimazaki; K Katoh; M Kumagawa; M Kikuchi
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

Review 2.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

3.  Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Journal:  Melanoma Res       Date:  2006-10       Impact factor: 3.599

4.  A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up.

Authors:  G J Weil; R M Ramzy; M El Setouhy; A M Kandil; E S Ahmed; R Faris
Journal:  Am J Trop Med Hyg       Date:  1999-07       Impact factor: 2.345

5.  Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia.

Authors:  Stefan Faderl; Kim-Anh Do; Marcella M Johnson; Michael Keating; Susan O'brien; Iman Jilani; Alessandra Ferrajoli; Farhad Ravandi-Kashani; Christine Aguilar; Amanda Dey; Deborah A Thomas; Francis J Giles; Hagop M Kantarjian; Maher Albitar
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

6.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

Authors:  J Holash; P C Maisonpierre; D Compton; P Boland; C R Alexander; D Zagzag; G D Yancopoulos; S J Wiegand
Journal:  Science       Date:  1999-06-18       Impact factor: 47.728

7.  Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever.

Authors:  Anon Srikiatkhachorn; Chuanpis Ajariyakhajorn; Timothy P Endy; Siripen Kalayanarooj; Daniel H Libraty; Sharone Green; Francis A Ennis; Alan L Rothman
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

8.  Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti.

Authors:  Gerusa Dreyer; David Addiss; John Williamson; Joaquim Norões
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-07-24       Impact factor: 2.184

9.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors.

Authors:  A Papapetropoulos; G García-Cardeña; T J Dengler; P C Maisonpierre; G D Yancopoulos; W C Sessa
Journal:  Lab Invest       Date:  1999-02       Impact factor: 5.662

10.  Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.

Authors:  Alexander Yaw Debrah; Sabine Mand; Sabine Specht; Yeboah Marfo-Debrekyei; Linda Batsa; Kenneth Pfarr; John Larbi; Bernard Lawson; Mark Taylor; Ohene Adjei; Achim Hoerauf
Journal:  PLoS Pathog       Date:  2006-09       Impact factor: 6.823

View more
  12 in total

Review 1.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

Review 2.  Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis.

Authors:  Sanjukta Chakraborty; Manokaran Gurusamy; David C Zawieja; Mariappan Muthuchamy
Journal:  Microcirculation       Date:  2013-07       Impact factor: 2.628

3.  Toll-like receptor- and filarial antigen-mediated, mitogen-activated protein kinase- and NF-κB-dependent regulation of angiogenic growth factors in filarial lymphatic pathology.

Authors:  Subash Babu; R Anuradha; N Pavan Kumar; P Jovvian George; V Kumaraswami; Thomas B Nutman
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

Review 4.  Insights into the pathogenesis of disease in human lymphatic filariasis.

Authors:  Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

Review 5.  Immunology of lymphatic filariasis.

Authors:  S Babu; T B Nutman
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

6.  Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.

Authors:  Tomer Avraham; Jamie C Zampell; Alan Yan; Sonia Elhadad; Evan S Weitman; Stanley G Rockson; Jacqueline Bromberg; Babak J Mehrara
Journal:  FASEB J       Date:  2012-11-27       Impact factor: 5.191

7.  Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti.

Authors:  Linda Batsa Debrah; Anna Albers; Alexander Yaw Debrah; Felix F Brockschmidt; Tim Becker; Christine Herold; Andrea Hofmann; Jubin Osei-Mensah; Yusif Mubarik; Holger Fröhlich; Achim Hoerauf; Kenneth Pfarr
Journal:  Hum Genomics       Date:  2017-11-09       Impact factor: 6.481

8.  Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.

Authors:  Alexander F Flynn; M Gordon Joyce; Rebekah T Taylor; Sasisekhar Bennuru; Alyssa R Lindrose; Spencer L Sterling; C Paul Morris; Thomas B Nutman; Edward Mitre
Journal:  PLoS Negl Trop Dis       Date:  2019-09-12

9.  Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis.

Authors:  Julio Furlong-Silva; Stephen D Cross; Amy E Marriott; Nicolas Pionnier; John Archer; Andrew Steven; Stefan Schulte Merker; Matthias Mack; Young-Kwon Hong; Mark J Taylor; Joseph D Turner
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

10.  Filarial excretory-secretory products induce human monocytes to produce lymphangiogenic mediators.

Authors:  Tiffany Weinkopff; Charles Mackenzie; Rob Eversole; Patrick J Lammie
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.